Home
Scott Dunseth Myers, Director: Zentalis Pharmaceuticals ZNTL Buy · Filed 25/04/30
Trade details
- Type
- Insider buy
- Amount
- $29,400
- Shares · price
- 21,000 sh · $1.40 a share
- Held after
- 281,192 sh
- Trade date
- 25/04/30
- Filed
- 25/04/30
- Days to filing
- 0 days
First buy since 2023
- Insiders buying this week
- 1 insiders
- Holding change
- +8.1%
Zentalis Pharmaceuticals trades, last 26 weeks
What else happened in Zentalis Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 25/03/31~25/05/30Scott Dunseth Myers's recent trades
- Scott Dunseth Myers
BuyDynavax Technologies
BuyDynavax Technologies
DVAX
$41.1K
3,800 sh
$41.1K
Filed 25/08/25
Traded 25/08/22
- Scott Dunseth Myers
BuyViridian Therapeutics, Inc.\DE
BuyViridian Therapeutics, Inc.\DE
VRDN
$101.5K
4,000 sh
$101.5K
Filed 23/04/12
Traded 23/04/12
- Scott Dunseth Myers
BuyViridian Therapeutics, Inc.\DE
BuyViridian Therapeutics, Inc.\DE
VRDN
$160.3K
5,500 sh
$160.3K
Filed 23/03/13
Traded 23/03/13
